Kiniksa Pharmaceuticals (United States)
Kiniksa is a global biopharmaceutical company focused on developing novel treatments for patients with significant unmet need.
Last updated September 1, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Kiniksa is a global biopharmaceutical company that finds and delivers novel treatments for patients with a significant unmet need. Founded in 2015, it focuses on immune modulation and has a portfolio including an FDA-approved therapy and clinical-stage assets.
History
Kiniksa was founded in 2015 as a global biopharmaceutical company dedicated to advancing novel, transformative therapies for patients with unmet medical needs, with a focus on cardiovascular diseases. The company has a portfolio that includes an FDA-approved therapy and clinical-stage assets.
Sources2 sources
Cite this profile: Cite the canonical profile. /brand-wiki/kiniksa-pharmaceuticals-united-states · Editorial policy · How profiles are compiled